Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-SARS-CoV-2 Related-SARS-CoV-2 Inhibitors-MAVDA-K-256
MAVDA-K-256

Chemical Structure : MAVDA-K-256

CAS No.:

MAVDA-K-256

Catalog No.: PC-28781Not For Human Use, Lab Use Only.

MAVDA-K-256 is a potent and selective inhibitor of SARS-CoV-2 mRNA cap guanine-N7 methyltransferase (MTase) NSP14 with IC50 of <0.15 nM, inhibits SARS-CoV-2 replication with IC50 of 24.6 nM in Huh-7.5 cells.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

MAVDA-K-256 is a potent and selective inhibitor of SARS-CoV-2 mRNA cap guanine-N7 methyltransferase (MTase) NSP14 with IC50 of <0.15 nM, inhibits SARS-CoV-2 replication with IC50 of 24.6 nM in Huh-7.5 cells.
MAVDA-K-256 engages NSP14 through the formation of a ternary complex with S-adenosyl-l-homocysteine, potently inhibiting its MTase activity.
MAVDA-K-256 demonstrates broad-spectrum antiviral activity against diverse hCoVs without targeting the host mRNA cap MTase.
MAVDA-K-256 inhibits the biochemical MTase activity of NSP14 proteins of hCoVs of different genera of the Coronaviridae family, with IC50 values of 18.1 and 8.4 nM (MERS), 11.9 and 5.6 nM (229E).
MAVDA-K-256 shows no inhibitory effects against a broad panel of 39 RNA, DNA, or protein MTases up to 10 uM.
MAVDA-K-256 demonstrates potent antiviral activity against α-hCoV-NL63 (EC50 = 0.72 μM) and α-hCoV-229E (EC50 = 1.22 μM), as well as β-hCoV-OC43 (EC50 = 0.2 μM), respectively.
MAVDA-K-256 shows antiviral efficacy in a K18-hACE2 transgenic mouse model of SARS-CoV-2 infection.

Physicochemical Properties

M.Wt 466.49
Formula C23H19FN4O4S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

6-fluoro-1-methyl-N-(3-methyl-4-(6-methyloxazolo[5,4-c]pyridin-2-yl)phenyl)-2-oxoindoline-5-sulfonamide

References

1. Meyer C, et al. J Med Chem. 2026 Nov 12;69(21):25760-25776.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: